Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amity Platt"'
Publikováno v:
Pharmacogenetics and Genomics. 26:370-380
Objective Exemestane (EXE) is a potent third-generation aromatase inhibitor used as endocrine therapy in breast cancer treatment and prevention. Characterization of its metabolic pathway is incomplete, with ambiguity existing in the identity of enzym
Autor:
Alexander A. Little, Zhaohui Zhu, Kiranjot K. Brar, Alisha A. McBride, Savanna R. Garcia, Amity Platt, Faya Zhang, Gary G. Meadows, Hui Zhang, Kari A. Gaither
Publikováno v:
Cancer immunology, immunotherapy : CII. 65(9)
ALT-803, a novel IL-15/IL-15 receptor alpha complex, and the tyrosine kinase inhibitor, sunitinib, were examined for their single and combined effects on the growth of subcutaneous B16BL6 melanoma and on lymph node and lung metastasis. The study was
Autor:
Kiran K. Brar, Kari A. Gaither, Savanna Castillo, Alisha A. McBride, Dung Luong, Amity Platt, Zhaohui Zhu, Alexander A. Little, Hui Zhang, Gary G. Meadows, Faya Zhang
Publikováno v:
Cancer Research. 75:1345-1345
Chronic alcohol consumption (CAC) is a risk factor for melanoma as well as other cancers and can result in decreased patient survival. We previously showed that CAC increases the percentage of IFN-γ-producing CD8+ T cells exhibiting a memory phenoty
Autor:
Alexander Little, Kari Gaither, Alisha McBride, Savanna Castillo, Kiran Brar, Amity Platt, Zhaohui Zhu, Faya Zhang, Dung Luong, Hui Zhang, Gary Meadows
Publikováno v:
The Journal of Immunology. 194:69.29-69.29
The immune enhancing IL-15 super agonist ALT-803 and Sunitinib, a tyrosine kinase inhibitor that inhibits immunosuppressive myeloid derived suppressor cells (MDSC) and T regulatory (Treg) cells, were examined for their single and combined effects on